{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:28:10Z","timestamp":1792099690823,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:00:00Z","timestamp":1645228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T00:00:00Z","timestamp":1645228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"NIHR Cambridge Biomedical Reserach Centre VHL Alliance UK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2022,5,18]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Von Hippel-Lindau (VHL) disease is an inherited tumour predisposition syndrome and a paradigm for the importance of early diagnosis and surveillance. However, there is limited information on the \u201creal world\u201d management of VHL disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A national audit of VHL disease in the United Kingdom.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>VHL disease was managed mostly via specialist clinics coordinated through regional clinical genetics services (but frequently involving additional specialties). Over the study period, 19 genetic centres saw 842 individuals (393 males, 449 females) with a clinical and\/or molecular diagnosis of VHL disease and 74 individuals (35 male, 39 female) with a prior risk of 50% (affected parent). All centres offered retinal, central nervous system and abdominal surveillance to affected individuals and at-risk relatives though surveillance details differed between centres (but complied with international recommendations). Renal lesions detected on the first surveillance scan were, on average, larger than those detected during subsequent scans and the larger the diameter at detection the greater the likelihood of early intervention.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In a state-funded health care system individuals with a rare inherited cancer predisposition syndrome are generally able to access appropriate surveillance and patient management is improved compared to historical data. The \u201creal world\u201d data from this study will inform the future development of VHL management protocols.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41416-022-01724-7","type":"journal-article","created":{"date-parts":[[2022,2,19]],"date-time":"2022-02-19T12:04:27Z","timestamp":1645272267000},"page":"1339-1345","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of tumour surveillance protocols and outcomes in von Hippel-Lindau disease in a national health service"],"prefix":"10.1038","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6226-6918","authenticated-orcid":false,"given":"Eamonn R.","family":"Maher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Adlard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Barwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela F.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Brennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian S.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabib","family":"Dabir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosemarie","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Dyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Forde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorothy","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Higgs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0612-8377","authenticated-orcid":false,"given":"Fiona","family":"Lalloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zosia","family":"Miedzybrodzka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Ren","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frauke","family":"Pelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Ruddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Snape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Whitworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard N.","family":"Sandford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,19]]},"reference":[{"key":"1724_CR1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1126\/science.8493574","volume":"260","author":"F Latif","year":"1993","unstructured":"Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al. Identification of the von Hippel-Lindau disease tumour suppressor gene. Science. 1993;260:1317\u201320.","journal-title":"Science"},{"key":"1724_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/ejhg.2010.175","volume":"19","author":"ER Maher","year":"2011","unstructured":"Maher ER, Neumann HP, Richard S. von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet. 2011;19:617\u201323.","journal-title":"Eur J Hum Genet"},{"key":"1724_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrc3844","volume":"15","author":"L Gossage","year":"2015","unstructured":"Gossage L, Eisen T, Maher ER. VHL, the story of a tumour suppressor gene. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Nat Rev Cancer. 2015;15:55\u201364.","journal-title":"Nat Rev Cancer"},{"key":"1724_CR4","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1200\/JCO.2015.65.6140","volume":"34","author":"SM Nielsen","year":"2016","unstructured":"Nielsen SM, Rhodes L, Blanco I, Chung WK, Eng C, Maher ER, et al. Von Hippel-Lindau Disease: Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome. J Clin Oncol. 2016;34:2172\u201381.","journal-title":"J Clin Oncol"},{"key":"1724_CR5","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","volume":"77","author":"ER Maher","year":"1990","unstructured":"Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, et al. Clinical features and natural history of von Hippel-Lindau disease. Q J Med. 1990;77:1151\u201363.","journal-title":"Q J Med"},{"key":"1724_CR6","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1097\/IAE.0000000000002572","volume":"39","author":"HE Wiley","year":"2019","unstructured":"Wiley HE, Krivosic V, Gaudric A, Gorin MB, Shields C, Shields J, et al. Management of retinal hemangioblastoma in von Hippel-Lindau Disease. Retina. 2019;39:2254\u201363.","journal-title":"Retina"},{"key":"1724_CR7","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/0002-9343(64)90107-X","volume":"36","author":"KL Melmon","year":"1964","unstructured":"Melmon KL, Rosen SW. Lindau\u2019s disease. Review of the literature and study of a large kindred. Am J Med. 1964;36:595\u2013617.","journal-title":"Am J Med"},{"key":"1724_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1148\/133.2.289","volume":"133","author":"WL Fill","year":"1979","unstructured":"Fill WL, Lamiell JM, Polk NO. The radiographic manifestations of von Hippel-Lindau disease. Radiology. 1979;133:289\u201395.","journal-title":"Radiology"},{"key":"1724_CR9","first-page":"133","volume":"134","author":"JS Green","year":"1986","unstructured":"Green JS, Bowmer MI, Johnson GJ. Von Hippel-Lindau disease in a Newfoundland kindred. CMAJ. 1986;134:133\u20138.","journal-title":"CMAJ"},{"key":"1724_CR10","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/0140-6736(91)91705-Y","volume":"337","author":"HP Neumann","year":"1991","unstructured":"Neumann HP, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet. 1991;337:1052\u20134.","journal-title":"Lancet"},{"key":"1724_CR11","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/ki.1996.395","volume":"50","author":"D Chauveau","year":"1996","unstructured":"Chauveau D, Duvic C, Chr\u00e9tien Y, Paraf F, Droz D, Melki P, et al. Renal involvement in von Hippel-Lindau disease. Kidney Int. 1996;50:944\u201351.","journal-title":"Kidney Int"},{"key":"1724_CR12","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/brain\/109.6.1297","volume":"109","author":"SM Huson","year":"1986","unstructured":"Huson SM, Harper PS, Hourihan MD, Cole G, Weeks RD, Compston DA. Cerebellar haemangioblastoma and von Hippel-Lindau disease. Brain. 1986;109:1297\u2013310.","journal-title":"Brain"},{"key":"1724_CR13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/humu.20385","volume":"28","author":"KR Ong","year":"2007","unstructured":"Ong KR, Woodward ER, Killick P, Lim C, Macdonald F, Maher ER. Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat. 2007;28:143\u20139.","journal-title":"Hum Mutat"},{"key":"1724_CR14","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/jmedgenet-2011-100562","volume":"49","author":"A Wilding","year":"2012","unstructured":"Wilding A, Ingham SL, Lalloo F, Clancy T, Huson SM, Moran A, et al. Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet. 2012;49:264\u20139.","journal-title":"J Med Genet"},{"key":"1724_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/01.ju.0000132127.79974.3f","volume":"172","author":"BG Duffey","year":"2004","unstructured":"Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, et al. The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol. 2004;172:63\u20135.","journal-title":"J Urol"},{"key":"1724_CR16","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/ncpuro0179","volume":"2","author":"RL Grubb 3rd","year":"2005","unstructured":"Grubb RL 3rd, Choyke PL, Pinto PA, Linehan WM, Walther MM. Management of von Hippel-Lindau-associated kidney cancer. Nat Clin Pr Urol. 2005;2:248\u201355.","journal-title":"Nat Clin Pr Urol"},{"key":"1724_CR17","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/S0022-5347(05)66524-X","volume":"165","author":"JC Herring","year":"2001","unstructured":"Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke PL, Walther MM. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol. 2001;165:777\u201381.","journal-title":"J Urol"},{"key":"1724_CR18","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.1093\/hmg\/4.11.2139","volume":"4","author":"FM Richards","year":"1995","unstructured":"Richards FM, Payne SJ, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet. 1995;4:2139\u20134.","journal-title":"Hum Mol Genet"},{"key":"1724_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/srep31128","volume":"6","author":"F Tabaro","year":"2016","unstructured":"Tabaro F, Minervini G, Sundus F, Quaglia F, Leonardi E, Piovesan D, et al. VHLdb: a database of von Hippel-Lindau protein interactors and mutations. Sci Rep. 2016;6:31128.","journal-title":"Sci Rep."},{"key":"1724_CR20","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1136\/jmg.34.9.746","volume":"34","author":"DG Evans","year":"1997","unstructured":"Evans DG, Maher ER, Macleod R, Davies DR, Craufurd D. Uptake of genetic testing for cancer predisposition. J Med Genet. 1997;34:746\u20138.","journal-title":"J Med Genet"},{"key":"1724_CR21","first-page":"B4763","volume":"60","author":"ML Binderup","year":"2013","unstructured":"Binderup ML, Bisgaard ML, Harbud V, M\u00f8ller HU, Gimsing S, Friis-Hansen L, et al. Von Hippel-Lindau disease (vHL). National clinical guideline for diagnosis and surveillance in Denmark. 3rd edition. Dan Med J. 2013;60:B4763.","journal-title":"Dan Med J"},{"key":"1724_CR22","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.1007\/s00345-020-03441-3","volume":"39","author":"J Chahoud","year":"2021","unstructured":"Chahoud J, McGettigan M, Parikh N, Boris RS, Iliopoulos O, Rathmell WK, et al. Evaluation, diagnosis and surveillance of renal masses in the setting of VHL disease. World J Urol. 2021;39:2409\u201315.","journal-title":"World J Urol"},{"key":"1724_CR23","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/jmg.33.2.120","volume":"33","author":"IR Maddock","year":"1996","unstructured":"Maddock IR, Moran A, Maher ER, Teare MD, Norman A, Payne SJ, et al. A genetic register for von Hippel-Lindau disease. J Med Genet. 1996;33:120\u20137.","journal-title":"J Med Genet"},{"key":"1724_CR24","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/IAE.0000000000001601","volume":"38","author":"X Chen","year":"2018","unstructured":"Chen X, Sanfilippo CJ, Nagiel A, Hosseini H, Mitchell D, McCannel CA, et al. Early detection of retinal hemangioblastpmas in von Hippel-Lindau disease using ultra-widefield fluorescein angiography. Retina. 2018;38:748\u201354.","journal-title":"Retina"},{"key":"1724_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/13816810.2019.1678177","volume":"40","author":"S Mansfield Smith","year":"2019","unstructured":"Mansfield Smith S, Makam R, Sullivan L, Sandford R, Allen L. Is ultra wide-field retinal imaging alone appropriate for retinal angioma screening in lower risk subjects attending Von Hippel-Lindau (VHL) clinics? Ophthalmic Genet. 2019;40:403\u20136.","journal-title":"Ophthalmic Genet"},{"key":"1724_CR26","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0168-9525(98)01558-3","volume":"14","author":"WG Kaelin Jr","year":"1998","unstructured":"Kaelin WG Jr, Maher ER. The VHL tumour-suppressor gene paradigm. Trends Genet. 1998;14:423\u20136.","journal-title":"Trends Genet"},{"key":"1724_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1148\/radiology.194.3.7862955","volume":"194","author":"PL Choyke","year":"1995","unstructured":"Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology. 1995;194:629\u201342.","journal-title":"Radiology"},{"key":"1724_CR28","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.3171\/2014.1.JNS131431","volume":"120","author":"RR Lonser","year":"2014","unstructured":"Lonser RR, Butman JA, Huntoon K, Asthagiri AR, Wu T, Bakhtian KD, et al. Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. 2014;120:1055\u201362.","journal-title":"J Neurosurg"},{"key":"1724_CR29","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3171\/jns.2003.98.1.0106","volume":"98","author":"RR Lonser","year":"2003","unstructured":"Lonser RR, Weil RJ, Wanebo JE, DeVroom HL, Oldfield EH. Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg. 2003;98:106\u201316.","journal-title":"J Neurosurg"},{"key":"1724_CR30","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3171\/2015.4.JNS1533","volume":"124","author":"K Huntoon","year":"2016","unstructured":"Huntoon K, Wu T, Elder JB, Butman JA, Chew EY, Linehan WM, et al. Biological and clinical impact of hemangioblastoma-associated peritumoral cysts in von Hippel-Lindau disease. J Neurosurg. 2016;124:971\u20136.","journal-title":"J Neurosurg"},{"key":"1724_CR31","doi-asserted-by":"publisher","first-page":"5003","DOI":"10.1200\/JCO.2020.38.15_suppl.5003","volume":"38","author":"E Jonasch","year":"2020","unstructured":"Jonasch E, Donskov F, Iliopoulos O, Kimryn Rathmell W, Narayan V, Maughan BL, et al. Phase II study of the oral HIF-2\u03b1 inhibitor MK-6482 for Von Hippel-Lindau disease\u2013associated renal cell carcinoma. J Clin Oncol. 2020;38:5003\u20135003.","journal-title":"J Clin Oncol"},{"key":"1724_CR32","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1093\/hmg\/3.8.1303","volume":"3","author":"PA Crossey","year":"1994","unstructured":"Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, et al. Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. Hum Mol Genet. 1994;3:1303\u20138.","journal-title":"Hum Mol Genet"},{"key":"1724_CR33","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/(SICI)1098-1004(1996)8:4<348::AID-HUMU8>3.0.CO;2-3","volume":"8","author":"B Zbar","year":"1996","unstructured":"Zbar B, Kishida T, Chen F, Schmidt L, Maher ER, Richards FM, et al. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan. Hum Mutat. 1996;8:348\u201357.","journal-title":"Hum Mutat"},{"key":"1724_CR34","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1001\/jama.1997.03540420057030","volume":"277","author":"TJ Manski","year":"1997","unstructured":"Manski TJ, Heffner DK, Glenn GM, Patronas NJ, Pikus AT, Katz D, et al. Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. JAMA. 1997;277:1461\u20136.","journal-title":"JAMA"},{"key":"1724_CR35","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/jmedgenet-2016-104058","volume":"54","author":"ML Binderup","year":"2017","unstructured":"Binderup ML, Jensen AM, Budtz-J\u00f8rgensen E, Bisgaard ML. Survival and causes of death in patients with von Hippel-Lindau disease. J Med Genet. 2017;54:11\u20138.","journal-title":"J Med Genet"},{"key":"1724_CR36","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/ajmg.a.33139","volume":"152A","author":"DG Evans","year":"2010","unstructured":"Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, et al. Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service. Am J Med Genet A. 2010;152A:327\u201332.","journal-title":"Am J Med Genet A"},{"key":"1724_CR37","first-page":"B5461","volume":"65","author":"ML Binderup","year":"2018","unstructured":"Binderup ML. von Hippel-Lindau disease: Diagnosis and factors influencing disease outcome. Dan Med J. 2018;65:B5461.","journal-title":"Dan Med J"},{"key":"1724_CR38","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1007\/BF00223868","volume":"95","author":"H Brauch","year":"1995","unstructured":"Brauch H, Kishida T, Glavac D, Chen F, Pausch F, H\u00f6fler H, et al. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum Genet. 1995;95:551\u20136.","journal-title":"Hum Genet"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01724-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01724-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01724-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T23:04:33Z","timestamp":1651014273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01724-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,19]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,5,18]]}},"alternative-id":["1724"],"URL":"https:\/\/doi.org\/10.1038\/s41416-022-01724-7","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,19]]},"assertion":[{"value":"25 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Approval for an audit of specialist services for VHL disease services was provided at each of the participating centres. Individual patient consent was not obtained.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"EM and JB have received compensation for participating in an expert forum meeting organised by Merck Sharp & Dohme. Other authors have no competing interests to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}